If you have TRICARE Prime or TRICARE Select, these medications are still covered in certain circumstances
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
Can oral options prevent future shortages
Medical weight loss with GLP-1 treatments Learn more about our science-backed, medically supervised weight loss program thats built around you
Increased satiety means people eat smaller, less frequent meals
"These products are often positioned as over-the-counter options that mimic the effects of GLP-1 medications, particularly for appetite control and weight management," says Catherine Metzgar, PhD, RD, director of coaching at Virta Health